Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Finished

SpikeZip SpikeZip: a retinomorphic encoding method for low-latency and loss-less data compression and telemetry of large-scale in-vivo neural recordings

Coordinator
Stichting IMEC Nederland, Netherlands
Runs
1 November 2023 to 30 April 2025
Status
Finished
EU funding
€150k
Total cost
—
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101138283

What the project is doing

In the project's own words, from its summary on CORDIS.

In-vivo neural recording and transmission of a vast number of neurons is essential in comprehending the brain and nervous system. However, the core challenge in the field of high-channel-count in-vivo neural recording is the limitation in transferring data posed by the bandwidth and energy consumption, which currently lacks a viable telemetry solution to effectively address this challenge. This PoC project introduces a novel retinomorphic encoding method, SpikeZip, which offers several advantages over existing approaches for processing neural data, such as low information loss, minimal latency, and reduced hardware overhead.

The technical advances demonstrated in this project will have significant impacts on various applications areas, such as neuroscience research with free-moving small animals, low-latency closed-loop neuromodulation, implantable brain-computer interfaces, and cognitive prosthetics. The proposed method has the potential to revolutionize the way we record and process neural data, enabling us to better understand the brain's cognitive functions and develop new therapies for various neurological disorders.

This PoC project will develop a robust demonstration system and rigorously validate it in small animal studies, with settings that can be effectively applied and translated across a diverse range of neuroscience and neurotherapeutic applications. SpikeZip will develop a go-to-market strategy that highlights the technology's unique features and benefits, with a focus on IP and licensing opportunities, and engaging with industry partners to identify promising commercialization opportunities.

Topics

Who is involved

OrganisationCityCountryRole
Stichting IMEC NederlandEindhovenNetherlandsCoordinator
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI